Literature DB >> 16204533

Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures.

Maddalena Rossi1, Claudio Corradini, Alberto Amaretti, Marcello Nicolini, Anna Pompei, Simona Zanoni, Diego Matteuzzi.   

Abstract

The utilization of fructooligosaccharides (FOS) and inulin by 55 Bifidobacterium strains was investigated. Whereas FOS were fermented by most strains, only eight grew when inulin was used as the carbon source. Residual carbohydrates were analyzed by high-performance anion-exchange chromatography with pulsed amperometric detection after batch fermentation. A strain-dependent capability to degrade fructans of different lengths was observed. During batch fermentation on inulin, the short fructans disappeared first, and then the longer ones were gradually consumed. However, growth occurred through a single uninterrupted exponential phase without exhibiting polyauxic behavior in relation to the chain length. Cellular beta-fructofuranosidases were found in all of the 21 Bifidobacterium strains tested. Four strains were tested for extracellular hydrolytic activity against fructans, and only the two strains which ferment inulin showed this activity. Batch cultures inoculated with human fecal slurries confirmed the bifidogenic effect of both FOS and inulin and indicated that other intestinal microbial groups also grow on these carbon sources. We observed that bifidobacteria grew by cross-feeding on mono- and oligosaccharides produced by primary inulin intestinal degraders, as evidenced by the high hydrolytic activity of fecal supernatants. FOS and inulin greatly affected the production of short-chain fatty acids in fecal cultures; butyrate was the major fermentation product on inulin, whereas mostly acetate and lactate were produced on FOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204533      PMCID: PMC1265942          DOI: 10.1128/AEM.71.10.6150-6158.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  41 in total

1.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 2.  Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.

Authors:  Alain L Servin
Journal:  FEMS Microbiol Rev       Date:  2004-10       Impact factor: 16.408

Review 3.  The control and consequences of bacterial fermentation in the human colon.

Authors:  J H Cummings; G T Macfarlane
Journal:  J Appl Bacteriol       Date:  1991-06

4.  Amino acids produced by bifidobacteria and some Clostridia.

Authors:  D Matteuzzi; F Crociani; O Emaldi
Journal:  Ann Microbiol (Paris)       Date:  1978 Aug-Sep

5.  Short chain fatty acid absorption by the human large intestine.

Authors:  N I McNeil; J H Cummings; W P James
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

6.  Effect of pH on bile salt degradation by mixed fecal cultures.

Authors:  I A Macdonald; G Singh; D E Mahony; C E Meier
Journal:  Steroids       Date:  1978-09       Impact factor: 2.668

7.  Short-chain fatty acids and bowel functions in man.

Authors:  T Høverstad; A Bjørneklett
Journal:  Scand J Gastroenterol       Date:  1984-11       Impact factor: 2.423

8.  Absorption of short-chain fatty acids by the colon.

Authors:  H Ruppin; S Bar-Meir; K H Soergel; C M Wood; M G Schmitt
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

9.  Short-chain fatty acids in the normal human feces.

Authors:  T Høverstad; O Fausa; A Bjørneklett; T Bøhmer
Journal:  Scand J Gastroenterol       Date:  1984-05       Impact factor: 2.423

10.  Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans.

Authors:  Gerald W Tannock; Karen Munro; Rodrigo Bibiloni; Mary A Simon; Patrick Hargreaves; Pramod Gopal; Hermie Harmsen; Gjalt Welling
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

View more
  103 in total

1.  Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial.

Authors:  Parvin Dehghan; Bahram Pourghassem Gargari; Mohammad Asgharijafarabadi
Journal:  Health Promot Perspect       Date:  2013-06-30

Review 2.  Prebiotics metabolism by gut-isolated probiotics.

Authors:  Muhamad Hanif Rawi; Siti Aisyah Zaman; Khairul Faizal Pa'ee; Sui Sien Leong; Shahrul Razid Sarbini
Journal:  J Food Sci Technol       Date:  2020-01-20       Impact factor: 2.701

Review 3.  The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.

Authors:  Quentin Le Bastard; Guillaume Chapelet; François Javaudin; Didier Lepelletier; Eric Batard; Emmanuel Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-09       Impact factor: 3.267

4.  Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and starch.

Authors:  Karen P Scott; Jenny C Martin; Christophe Chassard; Marlene Clerget; Joanna Potrykus; Gill Campbell; Claus-Dieter Mayer; Pauline Young; Garry Rucklidge; Alan G Ramsay; Harry J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  A Human Gut Commensal Ferments Cranberry Carbohydrates To Produce Formate.

Authors:  Ezgi Özcan; Jiadong Sun; David C Rowley; David A Sela
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

6.  Folate production by bifidobacteria as a potential probiotic property.

Authors:  Anna Pompei; Lisa Cordisco; Alberto Amaretti; Simona Zanoni; Diego Matteuzzi; Maddalena Rossi
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

Review 7.  Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials.

Authors:  F Liu; M Prabhakar; J Ju; H Long; H-W Zhou
Journal:  Eur J Clin Nutr       Date:  2016-09-14       Impact factor: 4.016

8.  Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine.

Authors:  Shari A Jones; Mathias Jorgensen; Fatema Z Chowdhury; Rosalie Rodgers; James Hartline; Mary P Leatham; Carsten Struve; Karen A Krogfelt; Paul S Cohen; Tyrrell Conway
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  Evaluation of Fructooligosaccharides and Inulins as Potentially Health Benefiting Food Ingredients by HPAEC-PED and MALDI-TOF MS.

Authors:  Chiara Borromei; Maria Careri; Antonella Cavazza; Claudio Corradini; Lisa Elviri; Alessandro Mangia; Cristiana Merusi
Journal:  Int J Anal Chem       Date:  2009-03-18       Impact factor: 1.885

Review 10.  Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

Authors:  Lay-Gaik Ooi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2010-06-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.